Altered Serum Annexin A2 Might Be a New Potential Diagnostic Biomarker in Human Colorectal Cancer.

CONCLUSIONS: Serum Annexin A2 may be a non-invasive and promising biomarker for the diagnosis of CRC, and the joint detection of Annexin A2 and CEA may have been favorable clinical applied value in the diagnosis of CRC.
PMID: 33334786 [PubMed - in process]

Source: Annals of Clinical and Laboratory Science - November 1, 2020 Category: Laboratory Medicine Authors: Hu D, Shen B, Yu M, Zha X, Zhou Y, Chen F, Ren J, Zhang L Tags: Ann Clin Lab Sci Source Type: research